Lopinavir protein binding in HIV-1-infected pregnant women-Reference-Cited by-同舟云学术

Lopinavir protein binding in HIV-1-infected pregnant women

Published:2010-04 Issue:4 Volume:11 Page:232-238
ISSN:1464-2662
Container-title:HIV Medicine
language:en
Short-container-title:

Author:

Aweeka FT,Stek A,Best BM,Hu C,Holland D,Hermes A,Burchett SK,Read J,Mirochnick M,Capparelli EV,

Publisher

Wiley

Subject

Pharmacology (medical),Infectious Diseases,Health Policy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1468-1293.2009.00767.x/fullpdf

Reference16 articles.

1. 1 USPHS Task Force Recommendations for the use of antiretroviral drugs in HIV-infected pregnant women for maternal health and interventions to reduce perinatal HIV transmission in the US. Available at http://aidsinfo.nih.gov/contentfiles/PerinatalGL.pdf (accessed 29 April 2009).

2. 2 Tracy TS , Venkataramanan R , Glover DD et al. Temporal changes in drug metabolism (CYP1A2, CYP2D6 and CYP3A activity) during pregnancy. Am J Obstet Gynecol 2005; 192: 633-639.

3. 3 Krauer B , Krauer F , Hytten FE. Drug disposition and pharmacokinetics in the maternal-placental-fetal unit. Pharmacol Ther 1980; 10: 301-328.

4. 4 Stek AM , Mirochnick M , Capparelli E et al. Reduced lopinavir exposure during pregnancy. AIDS 2006; 20: 1931-1939.

5. 5 Mirochnick M , Best BM , Stek AM et al. Lopinavir exposure with an increased dose during pregnancy. JAIDS 2008; 49: 485-491.

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efavirenz-Based Antiretroviral Therapy but Not Pregnancy Increased Unbound Piperaquine Exposure in Women during Malaria Chemoprevention;Antimicrobial Agents and Chemotherapy;2023-04-18

2. Antiretrovirals for Human Immunodeficiency Virus Treatment and Prevention in Pregnancy;Obstetrics and Gynecology Clinics of North America;2023-03

3. Impact of pregnancy on maternal pharmacokinetics of medications;Clinical Pharmacology During Pregnancy;2022

4. Clinical pharmacology of anti-infectives during pregnancy;Clinical Pharmacology During Pregnancy;2022

5. Characterization of Plasma Protein Alterations in Pregnant and Postpartum Individuals Living With HIV to Support Physiologically-Based Pharmacokinetic Model Development;Frontiers in Pediatrics;2021-10-13